Citations

Clear

949 citation(s) found for "Li, Bryan".

Immunovirologic Assessment of American Patients with Nasopharyngeal Carcinoma and Occult Primary Tumors
Coates, Harvey, Neel, H. Bryan, Pearson, Gary R.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | April 21, 2016 | Volume: 86 | Issue: 3 | Pages: No page available

10.1177/019459987808600309 | PMID 224361 Get It

The Epstein‐Barr virus (EBV) is closely associated with nasopharyngeal carcinoma, suggesting an etiologic relationship. We have undertaken studies (1) to quantitate the relationship between antibody titers to EBV‐associated antigens and nasopharyngeal carcinoma in American patients since most of the patients in previous studies were of either Asian or African descent and (2) to determine the relationship between antibody titers and the clinical course of disease. Sera from patients with primary or recurrent nasopharyngeal carcinoma and from patients in remission, from patients with various other head and neck tumors (including occult primary lesions and lymphomas), and from normal controls were titrated for IgG antibodies to viral capsid antigen (VCA) and early antigen and IgA antibodies to VCA, using indirect immunofluorescence procedures previously detailed. High titers of antibodies to EBV‐induced early antigen and VCA in the IgG fraction and VCA in the IgA fraction were frequently found in the sera of patients with nasopharyngeal carcinoma. A significant reduction in these titers was observed with clinical remission of the disease in treated patients. Preliminary findings suggest that EBV serology may be useful in the evaluation and treatment of patients with nasopharyngeal carcinoma and also in patients with cervical metastases from clinically occult primary sites in order to identify those with occult nasopharyngeal carcinoma.
Low incidence of primary biliary cirrhosis (PBC) in the first‐degree relatives of PBC probands after 8 years of follow‐up
Gulamhusein, Aliya , Juran, Brian D., Atkinson, Elizabeth J. , McCauley, Bryan M. , Schlicht, Erik M., Gulamhusein, Aliya F, McCauley, Bryan, Schlicht, Erik, Lazaridis, Konstantinos N.

Mayo Clinic

Liver International | April 10, 2016 | Volume: 36 | Issue: 9 | Pages: 1378-1382

10.1111/liv.13143 | PMID 27062298 Get It

AbstractBackground & AimsPrimary biliary cirrhosis (PBC) is characterized by chronic cholestasis and disease‐specific antimitochondrial antibodies (AMA). A high prevalence of AMAs in first‐degree relatives (FDRs) of PBC probands has been reported, although the natural history of such patients has not been described. We aimed to assess the risk of developing PBC in AMA+ FDRs of patients with PBC.MethodsFirst‐degree relatives recruited to the Mayo Clinic PBC Genetic Epidemiology Registry and Biorepository were followed for disease onset after recruitment. Development of PBC was ascertained via self‐report during a telephone interview and/or via proband report on a questionnaire. Chi‐squared test and t‐test were used to assess the differences between categorical and continuous variables respectively. A mixed‐effects model was used to assess the change in biochemical profiles over time.ResultsForty AMA+ and 423 AMA− subjects were included and followed for a median of 8.9 and 8.4 years respectively. Overall, 3% (n = 15) of FDRs were diagnosed with PBC, and AMA+ FDRs had a higher risk than AMA− FDRs (24% vs. 0.7%, P < 0.01). However, among undiagnosed FDRs, only 4% of AMA+ (n = 1) and 0.4% of AMA− (n = 1) FDRs were diagnosed with PBC (P = 0.17) during the follow‐up period. None of the AMA+ FDRs with normal alkaline phosphatase at baseline developed PBC in follow‐up.ConclusionsOur results suggest a low risk of developing PBC over time in FDRs of patients with PBC, particularly those without biochemical evidence of cholestasis at baseline. These data are useful in counselling and reassuring relatives of their overall favourable prognosis.
NASAL Manifestations of Allergic Granulomatosis and Angiitis (Churg‐Strauss Syndrome)
Olsen, Kerry D., Neel, H. Bryan, DeRemee, Richard A., Weiland, Louis H.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | April 8, 2016 | Volume: 88 | Issue: 1 | Pages: 85-89

10.1177/019459988008800120 | PMID 7393606 Get It

The tetrad of bronchial asthma, nasal disease, eosinophilia, and systemic vasculitis is the main feature of allergic granulomatosis and angiitis. Twenty‐two of 32 patients (69%) with this disorder had nasal manifestations, including nasal polyps, thick crusts, rhinitis, sinusitis, and occasionally septal perforations. Histopathologic study of involved tissue from the nose or subcutaneous nodules in conjunction with clinical evaluation will aid in establishing the correct diagnosis. Treatment with corticosteroids favorably influences symptoms and prognosis.
Laryngofissure and Cordectomy for Early Cordal Carcinoma: Outcome in 182 Patients
Neel, H. Bryan, Devine, Kenneth D., DeSanto, Lawrence W.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | April 8, 2016 | Volume: 88 | Issue: 1 | Pages: 79-84

10.1177/019459988008800119 | PMID 7393605 Get It

At the Mayo Clinic from 1962 to 1974, 182 patients with early squamous cell cancer of the true vocal cord were treated by laryngofissure and cordectomy. Seven patients (4%) had recurrences: four in the larynx and three in the neck (although the larynx was free of disease). The case histories of these patients are reported. Only three (2%) of the patients died as a consequence of their laryngeal cancer. The data substantiate our belief that the laryngofissure and cordectomy operation, and its minor variations, is an expeditious and highly successful means of eradicating glottic cancers.
Correlation of Preoperative Immunologic Test Results with Recurrence in Patients with Head and Neck Cancer
Ryan, Robert , Neel, H. Bryan, Ritts, Roy E.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | April 8, 2016 | Volume: 88 | Issue: 1 | Pages: 58-63

10.1177/019459988008800116 | PMID 6967203 Get It

Numbers and percentages of T and B cells in peripheral blood; blastogenic responses to PHA, Con A, and PWM; and serum levels of albumin, total protein, and IgA were assessed in patients with stages I to III operable squamous cell carcinoma of the upper aerodigestive passageways in the head and neck.The patients were categorized into two groups: those who remained tumor free and those in whom cancer recurred. It was found that pretreatment PHA‐ and Con A‐induced blastogenesis was often depressed in patients in whom clinically apparent recurrences developed regardless of stage or nodal involvement. This point is consistent with the idea that cellular immune function (blastogenesis) can identify, within the clinical staging system (TN), subpopulations of patients who are less likely to survive after conventional therapy.
Immunoglobulin a Antibody to Epstein‐Barr Viral Antigens and Prognosis in Nasopharyngeal Carcinoma
Mathew, Gregory D., Qualtiere, Louis F., Neel, H. Bryan, Pearson, Gary R., Mathew, Gregory Deepak

Mayo Clinic

Otolaryngology–Head and Neck Surgery | April 8, 2016 | Volume: 88 | Issue: 1 | Pages: 52-57

10.1177/019459988008800115 | PMID 6248828 Get It

IgA immunoglobulin fractions containing antibodies to Epstein‐Barr virus (EBV)‐induced membrane antigens were isolated from the sera of two patients with nasopharyngeal carcinoma (NPC), from one non‐NPC patient, and from three persons with sera negative for IgA antibodies. IgA antibodies were not cytotoxic against cells expressing EBV‐induced membrane antigens in the antibody‐dependent cellular cytotoxicity (ADCC) assay. However, IgA antibodies blocked IgG‐mediated ADCC, which indicated that these antibodies could serve as a blocking “factor” in patients with disease and, therefore, were potentially detrimental to the host.
Syncope
Cannon, Bryan C. , Wackel, Philip L. , Cannon, Bryan, Wackel, Philip

Mayo Clinic

Pediatrics In Review | April 1, 2016 | Volume: 37 | Issue: 4 | Pages: 159-168

10.1542/pir.2014-0109 | PMID 27037102 Get It

Improved Ventricular Function after TEE-guided Cardioversion of Atrial Arrhythmias in Patients after the Fontan Operation
Poterucha, Joseph T., Egbe, Alexander C. , Johnson, Jonathan N. , Wackel, Phillip L., Cannon, Bryan C. , Eidem, Benjamin W., Cetta, Frank , Niaz, Talha

Mayo Clinic

Congenital Heart Disease | March 31, 2016 | Volume: 11 | Issue: 6 | Pages: 578-583

10.1111/chd.12339 | PMID 27030521 Get It

Transcatheter Tricuspid Valve-in-Valve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valves
McElhinney, Doff B. , Eicken, Andreas , Boudjemline, Younès , Schubert, Stephan , Himbert, Dominique , Asnes, Jeremy D. , Salizzoni, Stefano , Bocks, Martin L. , Momenah, Tarek , Kim, Dennis W. , Schranz, Dietmar, Meadows, Jeffery , Thomson, John , Goldstein, Bryan H. , Crittendon, Ivory, Fagan, Thomas E. , Webb, John G. , Horlick, Eric , Delaney, Jeffrey W., Jones, Thomas K. , Shahanavaz, Shabana , Moretti, Carolina, Hainstock, Michael , Kenny, Damien , Berger, Felix , Rihal, Charanjit S. , Dvir, Danny , Cabalka, Allison K. , Aboulhosn, Jamil A, Cheatham, John P. , Momenah, Tarek S, Thomson, John D R, Hainstock, Michael R, Kenny, Damien P, Aboulhosn, Jamil , Cheatham, John P. , Rihal, Charanjit S. , McElhinney, Doff B , Goldstein, Bryan H

Mayo Clinic

Circulation | March 19, 2016 | Volume: 133 | Issue: 16 | Pages: 1582-1593

10.1161/circulationaha.115.019353 | PMID 26994123 Get It

Background— Off-label use of transcatheter aortic and pulmonary valve prostheses for tricuspid valve-in-valve implantation (TVIV) within dysfunctional surgical tricuspid valve (TV) bioprostheses has been described in small reports. Methods and Results— An international, multicenter registry was developed to collect data on TVIV cases. Patient-related factors, procedural details and outcomes, and follow-up data were analyzed. Valve-in-ring or heterotopic TV implantation procedures were not included. Data were collected on 156 patients with bioprosthetic TV dysfunction who underwent catheterization with planned TVIV. The median age was 40 years, and 71% of patients were in New York Heart Association class III or IV. Among 152 patients in whom TVIV was attempted with a Melody (n=94) or Sapien (n=58) valve, implantation was successful in 150, with few serious complications. After TVIV, both the TV inflow gradient and tricuspid regurgitation grade improved significantly. During follow-up (median, 13.3 months), 22 patients died, 5 within 30 days; all 22 patients were in New York Heart Association class III or IV, and 9 were hospitalized before TVIV. There were 10 TV reinterventions, and 3 other patients had significant recurrent TV dysfunction. At follow-up, 77% of patients were in New York Heart Association class I or II ( P <0.001 versus before TVIV). Outcomes did not differ according to surgical valve size or TVIV valve type. Conclusions— TVIV with commercially available transcatheter prostheses is technically and clinically successful in patients of various ages across a wide range of valve size. Although preimplantation clinical status was associated with outcome, many patients in New York Heart Association class III or IV at baseline improved. TVIV should be considered a viable option for treatment of failing TV bioprostheses.
Fungal Sinusitis in Healthy and Immunocompromised Individuals
Morgan, Margie, Wilson, Walter R. , Neel, H. Bryan, Roberts, Glenn D.

Mayo Clinic

American Journal of Clinical Pathology | March 18, 2016 | Volume: 82 | Issue: 5 | Pages: 597-601

10.1093/ajcp/82.5.597 | PMID 6496403 Get It